Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

Journal of Pathology

Volumn 203, Issue 2, 2004, Pages 631-637

  Hamming, I ^a   Timens, W ^a   Bulthuis, M L C ^a   Lely, A T ^a   Navis, G J ^a   van Goor, H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Angiotensin converting enzyme 2; Coronavirus; SARS CoV receptor; Severe acute respiratory syndrome (SARS)

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; MESSENGER RNA; UNCLASSIFIED DRUG; VIRUS RECEPTOR;

ADULT; AGED; ARTICLE; BONE MARROW; BRAIN; COLON; CONTROLLED STUDY; ENDOTHELIUM CELL; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE CELL; INTESTINE EPITHELIUM; KIDNEY; LIVER; LUNG; LUNG ALVEOLUS EPITHELIUM; LYMPH NODE; MALE; MOUTH MUCOSA; NASOPHARYNX; NOSE MUCOSA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RESPIRATORY SYSTEM; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; SKIN; SMALL INTESTINE; SMOOTH MUSCLE FIBER; SPLEEN; STOMACH; THYMUS; TISSUE DISTRIBUTION; VASCULAR ENDOTHELIUM; VIRUS IDENTIFICATION; VIRUS TRANSMISSION;

ARTERIES; ENTEROCYTES; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINE, SMALL; MALE; MIDDLE AGED; MUSCLE, SMOOTH; MUSCLE, SMOOTH, VASCULAR; PEPTIDYL-DIPEPTIDASE A; PULMONARY ALVEOLI; RECEPTORS, VIRUS; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; SKIN; VEINS; VIRAL PROTEINS;

EID: 2642539225     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1570     Document Type: Article

References (23)

1. Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003; 348: 1953-1966.
2. Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003; 348: 1967-1976.
3. Kuiken T, Fouchier RA, Schutten M, et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 2003; 362: 263-270.
4. Fouchier RA, Kuiken T, Schutten M, et al. Aetiology: Koch's postulates fulfilled for SARS virus. Nature 2003; 423: 240.
5. Ding Y, Wang H, Shen H, et al. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China. J Pathol 2003; 200: 282-289.
6. Cumulative number of reported probable cases of severe acute respiratory syndrome (SARS). http://www.who.int/csr/sars/country/2003_07_03. Accessed 8 July 2003.
7. Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003; 426: 450-454.
8. Harmer D, Gilbert M, Borman R, et al. Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett 2002; 532: 107-110.
9. Crackower MA, Sarao R, Oudit GY, et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 2002; 417: 822-828.
10. Donoghue M, Hsieh F, Baronas E, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000; 87: E1-E9.
11. Tikellis C, Johnston CI, Forbes JM, et al. Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension 2003; 41: 392-397.
12. Tipnis SR, Hooper NM, Hyde R, et al. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 2000; 275: 33 238-33 243.
13. To KF, Tong JHM, Chan PKS, et al. Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in-situ hybridization study of fatal cases. J Pathol 2004; 202: 157-163.
14. Yagil Y, Yagil C. Hypothesis: ACE2 modulates blood pressure in the mammalian organism. Hypertension 2003; 41: 871-873.
15. Nicholls JM, Poon LL, Lee KC, et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet 2003; 361: 1773-1778.
16. Peiris JS, Lai ST, Poon LL, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003; 361: 1319-1325.
17. Peiris JS, Chu CM, Cheng VC, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003; 361: 1767-1772.
18. Poutanen SM, Low DE, Henry B, et al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med 2003; 348: 1995-2005.
19. Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003; 348: 1986-1994.
20. Leung WK, To KF, Chan PK, et al. Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology 2003; 125: 1011-1017.
21. Wong RS, Wu A, To KF, et al. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. Br Med J 2003; 326: 1358-1362.
22. O'Donnell R. Tasker RC, Roe MF. SARS: understanding the coronavirus: apoptosis may explain lymphopenia of SARS. Br Med J 2003; 327: 620.
23. Zhang L, Huang Y, He T, et al. HIV-1 subtype and second-receptor use. Nature 1996; 383: 768.